002198 嘉应制药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.9712.7104.6026.219--
总资产报酬率 ROA (%)2.7012.4444.0515.313--
投入资产回报率 ROIC (%)2.8262.5834.3605.754--

边际利润分析
销售毛利率 (%)56.41359.93265.21065.33275.309
营业利润率 (%)8.7386.7147.5988.1740.936
息税前利润/营业总收入 (%)8.6596.3076.9927.4710.757
净利润/营业总收入 (%)7.4275.4796.4366.6650.257

收益指标分析
经营活动净收益/利润总额(%)104.837107.51696.055108.449517.223
价值变动净收益/利润总额(%)-0.4552.6902.8151.30419.265
营业外收支净额/利润总额(%)0.391-0.648-2.900-5.4547.645

偿债能力分析
流动比率 (X)15.15112.15311.7596.720--
速动比率 (X)12.37510.28610.0445.728--
资产负债率 (%)8.4839.6099.97913.965--
带息债务/全部投入资本 (%)0.3390.3260.2251.349--
股东权益/带息债务 (%)28,042.34429,248.73742,454.2846,972.824--
股东权益/负债合计 (%)1,078.865940.724902.103616.087--
利息保障倍数 (X)-76.312-17.324-17.835-26.683-2.949

营运能力分析
应收账款周转天数 (天)97.85183.53782.23466.3250.000
存货周转天数 (天)179.913202.617161.925122.5910.000